Related Experiment Video
Updated: Feb 6, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Function of GCN5 in the TGF-β1-induced epithelial-to-mesenchymal transition in breast cancer
Liming Zhao1, Aixia Pang2, Yunchun Li3
1Department of Nuclear Medicine, Linyi People's Hospital, Linyi, Shandong 276000, P.R. China.
Abstract:
Histone acetyltransferase GCN5 is a critical component of the TGF-β/Smad signaling pathway in breast cancer cells; however, it remains unknown whether it is involved in the development and progression of breast cancer. The present study investigated the role of GCN5 in the induction of the EMT by TGF-β1 in breast cancer cells and its underlying molecular mechanism of action. GCN5 activity was elevated and GCN5 mRNA expression and protein expression were increased in MDA-MB231 cells following stimulation with TGF-β1. Furthermore, TGF-β1 stimulation decreased expression of the epithelial cell marker E-cadherin and increased expression of the mesenchymal cell markers, N-cadherin and vimentin, as well as the expression of other EMT markers, including snail and slug. However, these changes were reversed following GCN5 knockdown leading to the downregulation of GCN5 expression. GCN5 knockdown also inhibited the viability, migration and invasion of MDA-MB231 cells, decreased the expression of p-STAT3, p-AKT, MMP9 and E2F1, and increased the expression of p21 in MDA-MB231 cells compared with cells stimulated with TGF-β1 alone. Therefore, GCN5 may work downstream of TGF-β/Smad signaling pathway to regulate the EMT in breast cancer.
Insights
Histone acetyltransferase GCN5 promotes breast cancer progression by regulating epithelial-mesenchymal transition (EMT). Inhibiting GCN5 reduces cancer cell viability, migration, and invasion, suggesting GCN5 as a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Histone acetyltransferase GCN5 (GCN5) is implicated in the TGF-β/Smad signaling pathway in breast cancer.
- The specific role of GCN5 in breast cancer development and progression remains unclear.
Purpose of the Study:
- To investigate the role of GCN5 in TGF-β1-induced epithelial-mesenchymal transition (EMT) in breast cancer cells.
- To elucidate the molecular mechanisms underlying GCN5's function in breast cancer progression.
Main Methods:
- Stimulation of MDA-MB231 breast cancer cells with TGF-β1.
- GCN5 knockdown using specific siRNAs.
- Analysis of EMT markers (E-cadherin, N-cadherin, vimentin, snail, slug).
- Assessment of cell viability, migration, invasion, and key signaling molecules (p-STAT3, p-AKT, MMP9, E2F1, p21).
Main Results:
- TGF-β1 stimulation increased GCN5 activity, mRNA, and protein expression in MDA-MB231 cells.
- TGF-β1 induced EMT, decreasing E-cadherin and increasing mesenchymal markers; these effects were reversed by GCN5 knockdown.
- GCN5 knockdown inhibited cell viability, migration, and invasion, and altered the expression of STAT3, AKT, MMP9, E2F1, and p21.
Conclusions:
- GCN5 plays a crucial role downstream of the TGF-β/Smad signaling pathway in regulating EMT in breast cancer.
- GCN5 inhibition suppresses breast cancer cell progression, highlighting its potential as a therapeutic target.
Related Concept Videos
Epithelial Tissues and Their Functions
Epithelial tissues provide the body's first line of protection from physical,...
Phase Transitions
Properties of Transition Metals
Cooperative Allosteric Transitions
TGF - β Signaling Pathway
Phase Transitions: Vaporization and Condensation

